English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model Journal article
Luo, Lidan, Wang, Shuai, Chen, Bohao, Zhong, Mei, Du, Ruili, Wei, Chun Shan, Huang, Furong, Kou, Xinhui, Xing, Yufeng, Tong, Guangdong. Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Luo, Lidan;  Wang, Shuai;  Chen, Bohao;  Zhong, Mei;  Du, Ruili; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:4.4/5.0 | Submit date：2023/01/31
Acute Liver Failure  Extracellular Hmgb1  Hmgb1-a Box  Inflammatory Injury  Tlr-4/nf-κb Signaling  
Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis Journal article
Chen, Mingtai, Liu, Mengnan, Guo, Xin, Zhou, Jie, Yang, Huayi, Zhong, Guofu, Men, Ling, Xie, Ying, Tong, Guangdong, Liu, Qiang, Luan, Jienan, Zhou, Hua. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis[J]. Phytomedicine, 2022, 104.
Authors:  Chen, Mingtai;  Liu, Mengnan;  Guo, Xin;  Zhou, Jie;  Yang, Huayi; et al.
Favorite | TC[WOS]:13 TC[Scopus]:11  IF:6.7/6.2 | Submit date：2023/01/30
Anxiety And Depression  Coronary Heart Disease  Meta-analysis  Percutaneous Coronary Intervention  Randomized Trial  Xinkeshu